Company attributes
Other attributes
Manifold Biotechnologies is a spinout from George Church’s lab at Harvard Medical School. It is a company that focuses on developing a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics.
Manifold Biotechnologies has the mission to develop technology that exponentially increases measurement throughput at every stage of drug development. Drug development teams often run into the bottleneck of testing only one molecule at a time in the most relevant biological assays and animals, Manifold focuses on developing a platform that eliminates this barrier and enables them and partners to pursue cures for diseases more rapidly.
Manifold believes that the technology and interdisciplinary team it is building will be able to bring the parallel economics of multiplexing to bear on engineering protein therapeutics and it believes new biologics can be discovered at scalethat by enabling high throughput in vivo screening of protein therapeutics.
